๐ฐ Urovant Sciences News
Page 3 - Urovant Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Urovant Sciences. Real-time updates on events, politics, business and more.
October 24, 2022
Although controversial, the practice of eliminating certain foods based on IgG antibody responses improved IBS symptoms in a new study.
September 23, 2022
/PRNewswire/ -- EVERSANA, a pioneer of next-generation commercial services to the global life sciences industry, today announced that EVERSANA INTOUCH was...
September 8, 2022
Interim 12-week analysis from the ongoing Phase 2a trial of an investigational novel gene therapy product, URO-902 (plasmid human cDNA encoding maxi-K channel), receives International Continence
September 7, 2022
Urovant Sciences, Inc. receives Fortuneand Great Place to Work Best Workplaces in BioPharma (2022) recognition. Follows Urovant's Best Place to Work recognition by the Orange County Business
July 13, 2022
Medical marketingโs biggest night is set for October 6 with a live gala at Cipriani Wall Street that will be streamed online.
July 13, 2022
Survey of 71 Directors of Nursing (DONs) highlights a need for improved awareness, education, and management of urinary incontinence (UI) related to overactive bladder (OAB) in long-term care (LTC)
July 13, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
July 7, 2022
This is Urovant's second year in a row to earn this recognition by Orange County Business Journal Urovant has also received a 2022 global Great Place to Work certification. The culmination
July 5, 2022
Pierre Fabre Médicament SAS (Pierre Fabre) to register and commercialize vibegron for the treatment of Overactive Bladder (OAB) in the Europe Economic Area, UK, and Switzerland. Urovant Sciences